-
View ModelCost-Effectiveness and Budget Impact Model of Future Developments With Whole-Genome Sequencing for Lung Cancer Patients
$1.00 Select options This product has multiple variants. The options may be chosen on the product page -
View ModelEarly cost-effectiveness model of whole genome sequencing as a molecular diagnostic test versus standard of care in locally advanced and metastatic (Stage IIIB,C/ IV) non-squamous non-small cell lung cancer
$1.00 Select options This product has multiple variants. The options may be chosen on the product page -
View ModelNSCLC simulation model
$1.00 Select options This product has multiple variants. The options may be chosen on the product page